Amplify Treatments, Testing And Advancements ETF ALT Holdings History
Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-38,577.33
% of Total Estimate Gain
-27.43%
Amplify Treatments, Testing and Advancements ETF's Altimmune Inc Holding Summary
As of 2024-06-30, Amplify Treatments, Testing and Advancements ETF held - shares of Altimmune Inc(ALT), totaling N/A. This investment constitutes 0% of their stock portfolio, and Amplify Treatments, Testing and Advancements ETF now holds 0% of the outstanding Altimmune Inc(ALT) stock.
The initial trade took place in 2024Q1. In addition, there have been 1 sales at an average price of $7.38 for 13,827.00 shares. Based on historical transaction data and ALT's current price of $4.08, Amplify Treatments, Testing and Advancements ETF's estimated gain on his ALT holdings is $-38,577.33, reflecting a -27.43% gain to date.
Amplify Treatments, Testing and Advancements ETF ALT ($4.08) Holding Chart
Amplify Treatments, Testing and Advancements ETF ALT ($4.08) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1